Commentary

The injustice of pre-authorization


 

Dr. Nasrallah responds

Thanks to all my colleagues who commented on (and unanimously agreed with) my editorial. It is clearly one of the most outrageous hurdles that all psychiatric practitioners face every day.

For the sake of our patients who deserve optimal medical care (laboratory tests, procedures, and medications), insurance companies must be tightly regulated to avoid second-guessing the treating clinicians, and readily cover what is prescribed. Some patients who can afford it resort to paying out of pocket for privacy reasons or for rapid access to psychiatric care, and may or may not file for insurance coverage, but they will certainly receive what their psychiatrist deems appropriate after a direct evaluation.

I hope the American Psychiatric Association and American Medical Asso­ciation will continue to forcefully pursue legislation to eliminate pre-authorization and restore some sanity to the critical process of good clinical care.

Henry A. Nasrallah, MD
Professor of Psychiatry, Neurology, and Neuroscience
Medical Director: Neuropsychiatry
Director, Schizophrenia and Neuropsychiatry Programs
University of Cincinnati College of Medicine
Cincinnati, Ohio
Professor Emeritus, Saint Louis University
St. Louis, Missouri

Pages

Recommended Reading

COVID-19 and Mental Health Awareness Month
MDedge Psychiatry
Many clinicians still not asking about postpartum depression
MDedge Psychiatry
Psychiatrists’ pay increases, most happy with income, career
MDedge Psychiatry
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
MDedge Psychiatry
Neuropsychiatric manifestations of COVID-19
MDedge Psychiatry
Life during COVID-19: A pandemic of silence
MDedge Psychiatry
The resident’s role in combating burnout among medical students
MDedge Psychiatry
Telepsychiatry during COVID-19: Understanding the rules
MDedge Psychiatry
Time series analysis of poison control data
MDedge Psychiatry
Armchair epidemiology
MDedge Psychiatry